platinum has been researched along with piperidines in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 6 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grant, CW; McConnell, HM; Wu, SH | 1 |
| Nigam, IC | 1 |
| Guttenplan, JB; Miller, P; Safirstein, R | 1 |
| Adjei, AA; Bruzek, LM; Davis, JN; Erlichman, C; Kaufmann, SH | 1 |
| Kim, KH; Kim, KM; Song, R | 1 |
| Brabec, V; Gibson, D; Kasparkova, J; Marini, V; Najajreh, Y; Novakova, O; Perez, JM | 1 |
| Ardeli-Tzaraf, Y; Barenholz, Y; Brabec, V; Gibson, D; Kasparkova, J; Khazanov, E; Najajreh, Y; Perez, JM; Prilutski, D | 1 |
| Cao, G; Huang, Y; Li, W; Liu, Q; Yao, S | 1 |
| Amiri-Kordestani, L; Banerjee, A; Beaver, JA; Blumenthal, GM; Charlab, R; Chen, XH; Dave, K; Dinin, J; Eradiri, O; Ghosh, S; Goldberg, KB; Horne, HN; Howie, LJ; Ibrahim, A; Ison, G; Janoria, KG; Kelly, SL; Kluetz, PG; Lee, EY; Li, F; Manheng, W; Palmby, TR; Pazdur, R; Philip, R; Pierce, WF; Pierre, V; Ramamoorthy, A; Song, P; Sridhara, R; Tang, S; Yu, J; Zhang, L | 1 |
| Konstantinopoulos, PA; Matulonis, UA | 1 |
| Cilibrizzi, A; Ferraro, G; Infrasca, T; Marzo, T; Merlino, A; Messori, L; Vilar, R | 1 |
| Wu, L; Zhong, L | 1 |
| Schorge, JO | 1 |
| Long, X; Zhou, Q; Zou, D | 1 |
| Alvarez, N; Colombo, N; dePont Christensen, R; Gonzalez Martin, A; Heitz, F; Marqués, C; Meirovitz, M; Sanchez Lorenzo, L; Sanchez, J; Selle, F; van Gorp, T | 1 |
| Liu, M; Liu, T; Sun, L; Tan, S; Tang, J; Xiao, W; Zhou, X | 1 |
| Choi, MC; Jeong, DH; Kim, BG; Kim, SI; Lee, JK; Lee, JY; Lim, MC; Park, J | 1 |
| Cancanelli, L; Chiumente, M; Di Spazio, L; Mengato, D; Messori, A; Rivano, M | 1 |
| Belotte, J; Clements, A; Fleming, EL; Gray, HJ; Gupta, D; Hamilton, E; Hardesty, MM; Keeton, EK; Konecny, GE; Krivak, TC; Moore, RG; Richardson, DL; Wang, P; Wright, GS | 1 |
| Domchek, SM; Donze, A; Gosselin, MK; Karasic, T; Massa, R; Mick, R; O'Hara, M; Onyiah, C; Reiss, KA; Schneider, C; Teitelbaum, U; Tondon, R; Vonderheide, RH | 1 |
4 trial(s) available for platinum and piperidines
| Article | Year |
|---|---|
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Double-Blind Method; Fallopian Tube Neoplasms; Female; Humans; Indazoles; Peritoneal Neoplasms; Piperidines; Platinum; Progression-Free Survival; Time Factors | 2021 |
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Ovarian Epithelial; Female; Humans; Indazoles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Republic of Korea | 2022 |
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Humans; Indazoles; Maintenance Chemotherapy; Ovarian Neoplasms; Piperidines; Platinum | 2022 |
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Hypertension; Immune Checkpoint Inhibitors; Indazoles; Ipilimumab; Nivolumab; Pancreatic Neoplasms; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors | 2022 |
16 other study(ies) available for platinum and piperidines
| Article | Year |
|---|---|
Lateral phase separations in binary lipid mixtures: correlation between spin label and freeze-fracture electron microscopic studies.
Topics: Binding Sites; Chromatography; Chromatography, Thin Layer; Fatty Acids, Unsaturated; Kinetics; Liposomes; Membranes, Artificial; Microscopy, Electron; Models, Biological; Palmitic Acids; Phosphatidylcholines; Piperidines; Platinum; Potentiometry; Silicon Dioxide; Spin Labels; Temperature | 1974 |
Reaction gas chromatography. I. Catalytic aromatization of alicyclic and heterocyclic compounds.
Topics: Alcohols; Amines; Catalysis; Chemical Phenomena; Chemistry; Chromatography, Gas; Cycloparaffins; Heterocyclic Compounds; Hydrocarbons; Ketones; Naphthalenes; Piperazines; Piperidines; Platinum; Pyrrolidines | 1966 |
Uptake and metabolism of cisplatin by rat kidney.
Topics: Animals; Binding Sites; Biological Transport; Biotransformation; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cisplatin; Kidney; Kidney Cortex; Male; Mutagenicity Tests; Organoplatinum Compounds; Piperidines; Platinum; Probenecid; Rats; Rats, Inbred Strains; Thiamine; Tolazoline | 1984 |
Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines.
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Apoptosis; Cell Cycle; Cisplatin; DNA Adducts; Drug Combinations; Drug Synergism; Fluorouracil; Humans; Melphalan; Piperidines; Platinum; Pyridines; Tumor Cells, Cultured | 2001 |
A metal-centered hydrophobic pocket recognizing pyridine over piperidine.
Topics: Copper; Cyclohexylamines; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Organometallic Compounds; Picolines; Piperidines; Platinum; Pyridines | 2003 |
Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
Topics: Animals; Antineoplastic Agents; Base Sequence; CHO Cells; Cisplatin; Cricetinae; Cross-Linking Reagents; DNA; DNA Adducts; DNA Polymerase I; Dose-Response Relationship, Drug; HeLa Cells; HIV Reverse Transcriptase; Humans; Hydroxyl Radical; Ligands; Models, Chemical; Models, Theoretical; Molecular Sequence Data; Oligonucleotides; Piperidines; Platinum; Time Factors | 2003 |
Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligand.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Crystallography, X-Ray; DNA; DNA Adducts; Humans; Inhibitory Concentration 50; Ligands; Molecular Structure; Organoplatinum Compounds; Piperidines; Platinum | 2005 |
Generation of gold nanostructures at the surface of platinum electrode by electrodeposition for ECL detection for CE.
Topics: Electrochemical Techniques; Electrodes; Electrophoresis, Capillary; Electroplating; Gold; Humans; Hydrogen-Ion Concentration; Luminescent Measurements; Metal Nanoparticles; Piperidines; Platinum | 2010 |
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy.
Topics: Aged; BRCA1 Protein; BRCA2 Protein; Clinical Trials as Topic; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Female; Germ-Line Mutation; Humans; Indazoles; Maintenance Chemotherapy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Progression-Free Survival; Risk Assessment | 2018 |
PARP Inhibitors in Ovarian Cancer: A Trailblazing and Transformative Journey.
Topics: Female; Humans; Indazoles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors | 2018 |
A case of extensive protein platination: the reaction of lysozyme with a Pt(ii)-terpyridine complex.
Topics: Crystallography, X-Ray; Dimethyl Sulfoxide; Hydrogen-Ion Concentration; Ligands; Lysine; Molecular Conformation; Muramidase; Organoplatinum Compounds; Piperidines; Platinum; Protein Binding; Pyridines; Spectrometry, Mass, Electrospray Ionization; Succinic Acid; Water | 2018 |
Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US.
Topics: Antineoplastic Agents; Budgets; Female; Health Expenditures; Humans; Indazoles; Models, Econometric; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phthalazines; Piperazines; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Progression-Free Survival; Survival Analysis; United States | 2019 |
Chemotherapy-free, but not quite free chemotherapy.
Topics: Bevacizumab; Female; Humans; Indazoles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Platinum | 2019 |
Chemotherapy-free strategy for platinum-sensitive recurrent ovarian cancer.
Topics: Bevacizumab; Female; Humans; Indazoles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Platinum | 2019 |
Chronic stress induces platinum and Niraparib resistance in mouse models of ovarian cancer.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Indazoles; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Models, Biological; Ovarian Neoplasms; Piperidines; Platinum; Stress, Psychological | 2022 |
Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy.
Topics: Carcinoma, Ovarian Epithelial; Female; Humans; Indazoles; Indoles; Ovarian Neoplasms; Phthalazines; Piperazines; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors | 2022 |